BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.97B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$613M |
| 3 |
SPDR S&P Biotech ETF
XBI
|
+$189M |
| 4 |
Canadian Pacific Kansas City
CP
|
+$138M |
| 5 |
Merck
MRK
|
+$134M |
Top Sells
| 1 |
Apple
AAPL
|
+$930M |
| 2 |
Bank of America
BAC
|
+$284M |
| 3 |
VanEck Gold Miners ETF
GDX
|
+$190M |
| 4 |
Canadian National Railway
CNI
|
+$184M |
| 5 |
Meta Platforms (Facebook)
META
|
+$143M |
Sector Composition
| 1 | Technology | 10.29% |
| 2 | Financials | 8.4% |
| 3 | Consumer Discretionary | 5.96% |
| 4 | Industrials | 5.95% |
| 5 | Healthcare | 5.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZOES
2276
DELISTED
Zoe's Kitchen, Inc.
ZOES
| $65.8K | ﹤0.01% |
1,607
+1,470
| +1,073% | +$60.2K |
|
|
BRKL
2277
DELISTED
Brookline Bancorp
BRKL
| $65.8K | ﹤0.01% |
5,827
+4,144
| +246% | +$46.8K |
|
|
WW
2278
DELISTED
WW International
WW
| $65.7K | ﹤0.01% |
13,551
-1,351
| -9% | -$6.55K |
|
2279
8x8 Inc
EGHT
$286M
| $65.7K | ﹤0.01% |
7,334
+5,234
| +249% | +$46.9K |
|
|
KEG
2280
DELISTED
KEY ENERGY SERVICES INC
KEG
| $65.5K | ﹤0.01% |
36,389
-29,596
| -45% | -$53.3K |
|
|
TARO
2281
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $65.2K | ﹤0.01% |
454
+430
| +1,792% | +$61.8K |
|
2282
Direxion NASDAQ-100 Equal Weighted Index Shares
QQQE
$1.21B
| $65.1K | ﹤0.01% |
2,000
| – | – |
|
2283
Brown-Forman Class A
BF.A
$13.2B
| $64.8K | ﹤0.01% |
+1,455
| New | +$64.8K |
|
|
RKUS
2284
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
| $64.8K | ﹤0.01% |
6,269
+4,717
| +304% | +$48.8K |
|
2285
WESCO International
WCC
$10.4B
| $64.6K | ﹤0.01% |
941
-32
| -3% | -$2.2K |
|
|
AIMC
2286
DELISTED
Altra Industrial Motion Corp.
AIMC
| $64.6K | ﹤0.01% |
2,376
+1,731
| +268% | +$47K |
|
|
STBZ
2287
DELISTED
State Bank Financial Corporation. Common Stock
STBZ
| $64.5K | ﹤0.01% |
2,973
+2,267
| +321% | +$49.2K |
|
2288
Novo Nordisk
NVO
$244B
| $64.4K | ﹤0.01% |
+2,352
| New | +$64.4K |
|
2289
WSFS Financial
WSFS
$3.13B
| $64.3K | ﹤0.01% |
2,351
+1,700
| +261% | +$46.5K |
|
2290
Azenta
AZTA
$1.36B
| $64.3K | ﹤0.01% |
5,614
+4,031
| +255% | +$46.2K |
|
2291
National Bank Holdings
NBHC
$1.46B
| $64.2K | ﹤0.01% |
3,082
+2,262
| +276% | +$47.1K |
|
2292
Sangamo Therapeutics
SGMO
$152M
| $64.2K | ﹤0.01% |
5,788
+4,179
| +260% | +$46.3K |
|
|
TWOU
2293
DELISTED
2U, Inc.
TWOU
| $64.2K | ﹤0.01% |
66
+58
| +725% | +$56.4K |
|
|
ININ
2294
DELISTED
Interactive Intelligence Group, inc.
ININ
| $64K | ﹤0.01% |
1,440
+1,040
| +260% | +$46.2K |
|
2295
HealthStream
HSTM
$855M
| $63.9K | ﹤0.01% |
2,101
+1,597
| +317% | +$48.6K |
|
2296
Heron Therapeutics
HRTX
$193M
| $63.9K | ﹤0.01% |
2,051
+1,505
| +276% | +$46.9K |
|
2297
Weis Markets
WMK
$1.75B
| $63.8K | ﹤0.01% |
1,514
+1,259
| +494% | +$53.1K |
|
|
CJES
2298
DELISTED
C&J ENERGY SVCS LTD
CJES
| $63.8K | ﹤0.01% |
4,831
+3,751
| +347% | +$49.5K |
|
2299
Calavo Growers
CVGW
$489M
| $63.6K | ﹤0.01% |
1,225
+882
| +257% | +$45.8K |
|
2300
Atara Biotherapeutics
ATRA
$85.1M
| $63.6K | ﹤0.01% |
48
+42
| +700% | +$55.6K |
|